Skip to content

Randomized controlled clinical trial of the efficacy and safety of Pediatric massage in the treatments of children's functional dyspepsia

Randomized controlled clinical trial of the efficacy and safety of Pediatric massage in the treatments of children's functional dyspepsia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17011685
Enrollment
Unknown
Registered
2017-06-17
Start date
2017-07-01
Completion date
Unknown
Last updated
2017-06-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional Dyspepsia

Interventions

Control Group:Domperidone

Sponsors

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 6 Years

Inclusion criteria

Inclusion criteria: 1. Children aged 3~6 years old, male and female; 2. Continuous or recurrent anorexia, early satiety and postprandial abdominal discomfort such as full bilge, or epigastric pain (navel); 3. After defecate cannot alleviate, or seizures has nothing to do with defecation frequency or excrement characters change (that is, except for irritable bowel syndrome); 4. No inflammatory, anatomy, metabolic or evidence of tumor diseases can explain the patient's symptoms; 5. At least 2 months prior to diagnosis, symptoms occur at least once a week; 6. The patient's legal guardian sign the informed consent, agreed to participate in research.

Exclusion criteria

Exclusion criteria: 1. Illnesses caused by anorexia, such as acute or chronic gastroenteritis, peptic ulcers, gastrointestinal surgery history, respiratory tract infection, acute or chronic hepatitis, anorexia and anorexia caused by certain drugs; 2. Children with moderate and severe malnutrition; 3. With cardiovascular, brain, lung, and children with severe primary diseases such as hematopoietic system; 4. Children with mental illness, dementia, discourse is not clear; 5. Allergic constitution , for a variety of drugs have allergy history; 6. Four weeks have participated in other clinical trials or with other drugs in clinical trials; 7. Application site have severe skin lesions or skin diseases; 8. According to the investigator, have lower possibility into the group or complicate the group or other lesions, such as the living environment is not stable, easy to cause such as traffic inconvenience lost to follow-up.

Design outcomes

Primary

MeasureTime frame
NDI;

Secondary

MeasureTime frame
EGG;height;weight;

Countries

China

Contacts

Public ContactQin Fan

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

fnqn2005@sohu.com+86 022-27432929

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026